MEDICAL PRODUCTS RECOVERY TEAM

File: 970107_sep96_decls28_0002.txt
Page: 0002
Total Pages: 2

Subject: MEDICAL PRODUCTS RECOVERY TEAM                                  

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003203

Folder Title: MEDICAL PRODUCTS RECOVERY TEAM                                                                  

Document Number:          1

Folder Seq  #:        186









           SUBZECT: Medical Products Recovery Team


           there                     doses of newly produced vaccine available
           and being stored by the manufacturer. Also, there ar-
           available at USAMRIID.        Because of the questionan.Le storage
           conditions in SWA, recommend disposal of the recovered vaccine.

                       (2) Botulinum pentavalent toxoid. Under provisions of
           IND regulations, 'Product could be retested for potency. Currently,
           there are                  doses at USAMRITD and approximately
           doses at the manufacturer in final stages of potency prior to
           release. The product manager at USAMMDA, Dr. Brandt, recommends
           temporarily holding the material.

                             otulinum antitoxin (equine). Currently, there are
                                                at USA?4RTTD.    Product could be
           retested ror potency. Dr. BrancLt recommend holding for contingency
           use, assuming retitering is completed.

                       (4)   Centoxin.    There are 120 vials at USAMRIID and
           additional supplies in Europe. Since the product was frozen, there
           is a concern about cryoprecipitates in an IV fluid. The product
           would require considerable retesting which would have to be
           conducted by the manufacturer. Since product expires August 91,
           disposal is recommended.

                       (5) Ribavirin. There are 375 treatment doses available
           at U      ID and 33 bottles (100 capsules/bottle) for prophylaxis.
           The product expires May 91, and the company is replacing 3,000
           vials at no charge. would recommend disposal of the product.





















                                                       COL NoMarlin/DSX 343-7137

Document 2 f:/Week-36/BX003203/MEDICAL PRODUCTS RECOVERY TEAM/medical products recovery team:01029715472429
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL PRODUCTS RECOVERY TEAM
Folder Seq # = 186
Subject = MEDICAL PRODUCTS RECOVERY TEAM
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997